The smartest way to use AI may not be letting it interact with your files, but asking it to write software that handles them ...

Hackers compromised 19 packages on the PyPI, collectively downloaded hundreds of thousands of times, in a new Shai-Hulud ...

Perplexity's Search as Code lets AI agents generate Python search workflows, but claimed token savings and benchmark gains ...

Claude Code Dynamic Workflows, launched May 28, 2026, replaces context-window orchestration with a JavaScript script Claude writes on the fly for each task. Runs cap at 1,000 parallel subagents with ...

Back in 2023, Chris Lattner, creator of LLVM, and his team at Modular unveiled a new language called Mojo. Its syntax resembled Python, but it compiled to machine-native code and offered memory-safety ...

Ever wondered when you created your Spotify account? Or which song you listened to first on the app? Well, now you can revisit these moments through the music streaming platform's new feature. For the ...

The Google I/O annual developer conference is around the corner—May 19—but in what is quickly becoming a tradition, Google announced new features for Android and Gemini a week early. The news came on ...

TAMPA, Fla.--(BUSINESS WIRE)--Concurrent Investment Advisors, LLC (“Concurrent”) has partnered with TAVO Wealth (“TAVO”), providing strategic transition guidance and support as the team launched its ...

Highlights of Python 3.15, now available in beta, include lazy imports, faster JITs, better error messages, and smarter profiling. The first full beta of Python 3.15 ...

I spoke with a doctor at Apple to learn more about the Apple Watch health features that you might not currently be using to support your wellness. Anna Gragert Senior Editor, Health and Home Anna ...

The Bahrain-based lender lets institutional clients convert fiat currency to US dollar-pegged stablecoins directly from their accounts. Singapore Gulf Bank (SGB) has introduced a service that lets ...

REDWOOD CITY, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today ...